Overview
- 140 inspections across 102 sites are on record.
- 99 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-05-04.
At a glance
Inspections
140
Sites
102
Observations
99
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Novo Nordisk A/S | 4 May 2023 | Biologics | On file |
| Sanofi Winthrop Industrie | 25 Apr 2023 | Human Drugs | On file |
| Unigen Inc. | 10 Mar 2023 | Biologics | On file |
| Unigen Inc. | 9 Mar 2023 | Biologics | On file |
| Samsung Biologics Co., Ltd. | 28 Feb 2023 | Biologics | On file |
Sites inspected
Novo Nordisk A/SKalundborg, Denmark1 insp.
Sanofi Winthrop IndustrieLe Trait, France1 insp.
Unigen Inc.Ibi-Gun, Japan2 insp.
Samsung Biologics Co., Ltd.Yeonsu District, Korea (the Republic of)1 insp.
Co-investigators
Investigators who share inspections with this person.
Burnell M Henry17 shared
Anissa M Cheung5 shared
Unnee Ranjan4 shared
Christian Lynch4 shared
Jacqueline M Diaz Albert4 shared
Cynthia Jim4 shared
Mikhail V Ovanesov3 shared
Laurel A Beer3 shared
Debra M Emerson3 shared
Nimmy Mathews3 shared
Full investigator report
Get the verbatim findings behind Prabhu P Raju's 99 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site